Adagio Medical (ADGM) awards director Orly Mishan 100,000 stock options at $0.71
Rhea-AI Filing Summary
Adagio Medical Holdings, Inc. director Orly Mishan received a grant of 100,000 non-qualified stock options on June 16, 2026 under the company’s Non-Employee Director Compensation Policy and 2024 Equity Incentive Plan. The options have an exercise price of $0.7103 per share and expire on June 16, 2036. They vest in equal monthly installments over one year, with 1/12 of the underlying shares vesting after each month of continuous service following the vesting commencement date of June 16, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
MISHAN ORLY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-qualified stock option (right to buy) F1 | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Non-qualified stock option (right to buy) — 100,000 shares (Direct)
Footnotes (1)
- F1. Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Key Figures
Options granted: 100,000 shares
Exercise price: $0.7103 per share
Expiration date: June 16, 2036
+1 more
4 metrics
Options granted
100,000 shares
Non-qualified stock options granted to director Orly Mishan on June 16, 2026
Exercise price
$0.7103 per share
Conversion or exercise price for the 100,000 stock options granted
Expiration date
June 16, 2036
Option expiration for Orly Mishan’s 100,000 non-qualified stock options
Post-transaction option holdings
100,000 options
Total non-qualified stock options held directly by Orly Mishan after the grant
Key Terms
Non-qualified stock option, Equity Incentive Plan, vesting commencement date, Non-Employee Director Compensation Policy
4 terms
Non-qualified stock option financial
"Non-qualified stock option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Equity Incentive Plan financial
"under the Issuer's 2024 Equity Incentive Plan (the "Option")."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting commencement date financial
"after the vesting commencement date of 06/16/2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Non-Employee Director Compensation Policy financial
"under the Issuer's Non-Employee Director Compensation Policy"
FAQ
What insider transaction did Adagio Medical (ADGM) report for Orly Mishan?
Adagio Medical reported that director Orly Mishan received a grant of 100,000 non-qualified stock options on June 16, 2026. The options relate to common stock and were issued as part of the company’s Non-Employee Director Compensation Policy and 2024 Equity Incentive Plan.
What is the exercise price of the newly granted ADGM stock options to Orly Mishan?
The granted options to Orly Mishan have an exercise price of $0.7103 per share. These options are non-qualified stock options for Adagio Medical common stock and were awarded under the company’s 2024 Equity Incentive Plan and director compensation policy.
How many Adagio Medical (ADGM) options does Orly Mishan hold after this grant?
Following this transaction, Orly Mishan holds 100,000 non-qualified stock options directly. All of these options relate to Adagio Medical common stock and arise from the June 16, 2026 grant reported in the Form 4 filing.
What are the vesting terms of Orly Mishan’s new ADGM stock options?
The options vest over one year in equal monthly installments. Specifically, 1/12 of the shares underlying the option vest at the conclusion of each month of continuous service after the vesting commencement date of June 16, 2026.
When do Orly Mishan’s Adagio Medical (ADGM) options expire?
The non-qualified stock options granted to Orly Mishan on June 16, 2026 have an expiration date of June 16, 2036. After that date, any unexercised portion of the option will no longer be exercisable under the plan terms.
Were Orly Mishan’s ADGM option grants made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative, indicating the grant was not reported as made pursuant to a Rule 10b5-1 trading plan. The transaction is characterized as a grant or award under compensation policies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
